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IMMUNOLOGIC CHARACTERISTICS OF NERVES WITHIN 
OSTEOARTHRITIC MARROW REGIONS OF HUMAN FEMORAL HEADS 
SONALI RATHOD 
ABSTRACT 
 Osteoarthritis (OA) is the most common degenerative joint disease, affecting 
primarily the hip, knee, and hand (Ip 2005). OA of the knee and hip is the 11th highest 
contributor to global disability (Cross et al. 2014). Hip OA is diagnosed using 
radiographs, computed tomography (CT), and/or magnetic resonance imaging (MRI).  
Hip OA affects the whole hip joint, causing pain and reduced range of motion (Altman et 
al. 1991). The cause of pain in OA is not well understood, but it may be attributed to 
abnormal growth of blood vessels and nerves in the subchondral bone of the femoral head 
(Kumar et al. 2013). Quantifying blood vessels and nerves and correlating their presence 
with diagnostic techniques such as MRI will establish a relationship between femoral 
head degeneration and pain levels and current diagnostic signs. 
 The aims of this study were: (1) to develop a reproducible histological technique 
to identify blood vessels and nerves in bone sections; and (2) to apply this protocol to 
identify blood vessel and nerve characteristics within osteoarthritic femoral heads.  
 Femoral heads were retrieved from 8 OA patients (age range: 40-76; 5 female and 
3 male) undergoing total hip replacement surgery.  Each sample was evaluated for the 
presence of subchondral bone cysts using micro-computed tomography (µCT), then 
regions containing cysts were isolated and dissected for histological processing. Different 
fixation times in paraformaldehyde (PFA) were tested in three samples to assess the 
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effect of fixation time on binding of the primary antibody to the target. Samples were 
stained with hematoxylin and eosin to evaluate overall tissue morphology, safarin-O and 
fast green to visualize the integrity of articular cartilage, anti-CD31 to identify vascular 
endothelium, and anti-PGP 9.5 to identify peripheral nerve fibers.  
A protocol was successfully developed to identify CD31-positive blood vessels 
and PGP 9.5-positive nerves in osteoarthritic femoral heads. The immunohistochemistry 
protocols for staining with anti-CD31 and anti-PGP 9.5 were optimized for maximum 
intensity of target staining, minimal background staining, and minimal artefactual tissue 
folding. Fixation time in PFA was not found to have an effect on quality of staining with 
anti-CD31. 
Blood vessels were found in all eight of the samples collected, and peripheral 
nerves were found in five of the samples.  Special attention was paid to regions with 
fibrous subchondral bone cysts, because these are the most likely type to undergo 
neurovascular invasion. Out of the five samples with fibrous subchondral bone cysts, 
blood vessels were identified in all five cyst regions, and peripheral nerves were 
identified in three cyst regions. 
Using the protocols developed in this study, blood vessels and nerves were found 
in osteoarthritic femoral heads. In future, a larger sample set will be used to correlate the 
nature of blood vessel density and nerves that are found in bone marrow lesions identified 
on MRI scans obtained before surgery and are associated with bone cysts. This is an 
important step towards identifying more effective treatments for OA that address the 
specific underlying causes and the development of non-treatable pain.  
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INTRODUCTION 
 
Osteoarthritis Epidemiology 
 Osteoarthritis (OA) is the most common degenerative joint disease (DJD). 
Patients with symptomatic OA complain of pain that worsens with weight-bearing 
activity, morning stiffness, and stiffness after periods of inactivity (Gamble et al. 2000). 
Hip OA causes reduced range of motion, radiographic joint space narrowing, and 
subchondral cyst formation or osteophytes (Altman et al. 1991).These structural changes 
are detectable on x-ray before they cause symptoms, necessitating the distinction between 
radiographic OA and symptomatic OA (Neogi and Zhang 2013). OA involves 
degeneration and remodeling of articular cartilage, although it’s a whole organ disease 
and all tissues of the synovial joint- cartilage, subchondral bone, synovium, ligament, 
capsule, and muscles- participate in the disease progression. OA can affect any synovial 
joint, but is most common in the knee, hip, and hand (Ip 2005). 
OA affects roughly 10% of males and 18% of females over age 60 (Glyn-Jones et 
al. 2015). Hip and knee osteoarthritis were ranked by the Global Burden of Disease study 
in 2010 as the 11th highest contributor to global disability (Cross et al. 2014). The 
Johnston County OA Project found radiographic hip OA to be present in approximately 
28% of their cohort of 3000 people age 45 and older. Additionally, it was found that 
women had a higher prevalence than men, and that African American men had a higher 
prevalence than Caucasian men (Jordan et al. 2009). There was no difference between 
African American and Caucasian women (Jordan et al. 2009). Prevalence of hip OA 
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increases linearly with age (Cross et al. 2014). Thus, an increase in total hip OA cases is 
anticipated to increase as the population ages.  
 
Primary vs. Secondary OA 
 Primary OA is due to an idiopathic cause, and is diagnosed by exclusion (Ip 
2005). Age is the primary factor predisposing an individual to primary OA. Other major 
predisposing factors act by changing the load experienced by the hip joint: obesity, 
abnormal gait, and heavy manual labor (Roach, H and Tilley, S 2007). Ethnicity, 
genetics, and sex also predispose individuals to primary OA. Females have a higher 
prevalence and greater severity of OA, though the exact mechanism for the difference 
between OA progression in women and men has not been elucidated (Neogi and Zhang 
2013). Secondary OA develops due to an underlying condition. Diagnoses leading to 
secondary OA include avascular necrosis (AVN), Paget’s disease, inflammatory arthritis, 
trauma, developmental hip dysplasia (DDH), and Perthes disease (Ip 2005). 
 
Osteoarthritis Treatment 
 There is no known cure for OA, so treatment for the disease consists of pain 
management. Physical and occupational therapists provide essential support and guidance 
for patients with OA. Physical therapists instruct patients on how and when to use heat, 
exercises, and assistive devices such as canes to relieve discomfort and improve range of 
motion. Quadriceps strengthening and aerobic exercise are especially important for 
patients with hip OA (Gamble et al. 2000). Aerobic exercise was found to improve hip 
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function and decrease pain (Tak et al. 2005). Occupational therapists can help patients 
protect the hip joint by using medical devices like splints (Gamble et al. 2000). In 
addition to physical therapy, patients with mild or moderate symptomatic OA may relieve 
pain by taking nonsteroidal anti-inflammatory drugs (NSAIDs) or acetaminophen. 
Patients with severe symptomatic OA can be treated with the synthetic opioid agonist 
Tramadol, or more potent opioid therapy. The American College of Rheumatology 
recommends pharmacologic therapy only in conjunction with physical and/or 
occupational therapy (Gamble et al. 2000). 
 Patients with severe symptomatic OA who have unsuccessfully tried to control 
their pain with the aforementioned therapies may be candidates for total hip arthroplasty 
(THA) (Gamble et al. 2000). In 2003, 202,500 THAs were performed in the United 
States- a number that Kurtz et al. projected to grow to 572,000 by 2030 (Kurtz 2007). 
93% of THAs performed in the UK are on patients with the chief complaint of 
untreatable pain since THA is a cost-effective procedure that yields pain relief and regain 
of hip joint function (Pivec et al. 2012). Patient selection requires assessing factors 
including obesity, medical history, and age (Pivec et al. 2012). Patients older than 65 
have increased risk of complications. Patients younger than 50 will put more stress on 
their prosthetic, which will affect the longevity of the replacement (Pivec et al. 2012). 
The success of this surgical technique, as well as the future of OA treatment, relies on 
understanding of normal bone and cartilage physiology, as well as the pathophysiology of 
OA. 
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Normal Bone Physiology 
 Bone is a specialized type of connective tissue that provides structural support, 
protects organs, acts as a reservoir for calcium and phosphate, and produces constituents 
of blood (Mescher 2016). Bone can be subdivided into compact or cortical bone, and 
cancellous or trabecular bone (Barrett et al. 2016). The outer portion of long bones such 
as the femur are composed of compact bone, whereas the interior marrow cavity is 
composed of trabecular bone (Barrett et al. 2016). Both types of bone are highly 
vascularized, since blood flow is important for hormone balance, bone remodeling, and 
repair (Lafage-Proust et al. 2015). 
  
Figure 1: Compact and cancellous bone. Left: Coronal section of the proximal end of 
the right femur (Gray 1918). Right: 10x photo of the superficial edge of a bone showing 
the two different structures (Mescher 2016). 
 
Bone, like other types of connective tissue, is composed of cells and extracellular 
matrix. The principle cell types in bone are osteoblasts, osteoclasts, and osteocytes. 
Osteoblasts are bone matrix-secreting cells derived from mesenchymal stem cells. As 
they secrete bone matrix, osteoblasts ultimately surround themselves with it and become 
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osteocytes (Mescher 2016). Osteocytes are housed in structures called lacunae, and 
connect with the vasculature through Haversian and Volkmann canals to send and receive 
nutrients (Barrett et al. 2016). Osteoclasts are large, multi-nucleated cells derived from 
the monocyte lineage, and function to reabsorb bone. Bone reabsorption occurs in an area 
sealed off by the osteoclast, called Howship’s lacuna. The osteoclast pumps protons into 
Howship’s lacuna, thereby acidifying and eroding the hydroxyapatite crystals of the bone 
extracellular matrix (ECM). Proteases are also released into Howship’s lacuna, which 
degrade collagen. The degraded ECM is transcytosed across the osteoclast and released 
into the interstitial space.  
Bone remodeling is a constant process involving all three of these cells acting 
synergistically (Mescher 2016), and is under both local paracrine and systemic hormonal 
control (Barrett et al. 2016). Osteoblasts express receptor activator for nuclear factor 
kappa-B ligand (RANKL) on their cell surface- the ligand for receptor activator for 
nuclear factor kappa-B (RANK) expressed on the surface of monocytes. When RANKL 
activates RANK, monocytes differentiate into osteoclasts (Barrett et al. 2016). After 
osteoclasts break down bone, osteoblasts rebuild bone in the spaces left behind (Barrett et 
al. 2016). 
Bone matrix contains hydroxyapatite crystals composed of calcium phosphate, as 
well as type I collagen, proteoglycans, and glycoproteins (Mescher 2016). 99% of the 
body’s calcium is stored in bone. Calcium is an important ion for muscle contraction and 
nerve function, among many other things. Parathyroid Hormone (PTH) acts directly on 
bone to increase bone resorption and therefore increase Calcium concentration in the 
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blood. Calcitonin, produced by the thyroid, directly inhibits bone resorption by acting on 
osteoclasts, therefore decreasing blood calcium levels (Barrett et al. 2016). Because 90% 
of the organic matter is type I collagen, bone tissue is acidophilic after decalcification.  
Bone remodeling is important not only for mineral metabolism, but for bone 
repair and maintenance of skeletal strength. Fracture repair requires bone remodeling to 
reshape the bone callus forming in the fracture gap. Blood released from vessels broken 
during fracture forms a clot. The clot is gradually broken down by macrophages, and a 
fibrocartilaginous procallus forms. The procallus is invaded by new blood vessels and 
osteoblasts. A hard callous is formed by osteoblasts depositing woven bone- a loosely 
organized type of bone. This bone will be remodeled by osteoclasts and osteoblasts into 
compact or trabecular bone, at which point the original morphology is restored (Mescher 
2016). 
 
Normal Cartilage Physiology 
Cartilage, like bone, is a special type of connective tissue. Articular cartilage can 
act to absorb impact because of its extracellular matrix (Roach, H and Tilley, S 2007). 
70-80% of cartilage is water. 15% is collagen, of which type II is most prevalent. Type II 
collagen creates an underlying fibrous scaffold, which holds proteoglycan molecules into 
place and imparts incompressible strength (Figure 2). Aggrecan accounts for 9% of 
cartilage. Proteoglycans are composed of hyaluronic acid and chondroitin sulfate 
interacting with aggrecan. They are highly hydrophilic due to their large number of fixed 
negative charges and will bind large volumes of water, thus providing the main 
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compressor physical property to the cartilage tissue. When cartilage is compressed, water 
is pushed away briefly, but the proteoglycans draw water back to it quickly causing the 
cartilage matrix to regain its original shape (Aigner and Stove, J 2003). While 
chondrocytes, the resident cells of cartilage, are important for creating the extracellular 
matrix, they do not directly provide structural support or elasticity for the tissue (Felson 
2015). 
 
Figure 2: Cartilage Matrix Composition. Type II collagen fibrils with proteoglycans 
interspersed (modified from Mescher 2013). 
 
Healthy articular cartilage is resistant to vascularization and is aneural (Sunita 
Suri and Walsh 2012). Chondrocytes receive nutrients and excrete waste into the water of 
the ECM, and blood vessels usually exist only in the synovium and subchondral bone 
(Sunita Suri and Walsh 2012). 
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The Hip Joint 
 The ball-and-socket structure of the hip, or femoroacetabular, joint reflects its 
function as the major weight-bearing joint in the human body. The acetabulum of the 
pelvis articulates inferior/mediolaterally with the femoral head. The articular cartilage, 
bones of the femur and hip, ligaments, and muscles crossing the hip joint impart stability. 
The muscles of the hip joint are the strongest in the body (Feeko and Mallow 2015). 
 The hip joint is a synovial joint, and thus has a synovium composed of adipose 
tissue, fibroblasts, and macrophages. Synovial fibroblasts secrete synovial fluid, which 
serves as a joint protector along with the stabilizing structures of the hip. Synovial fluid 
reduces friction between articular cartilage of the acetabulum and femoral head, and is 
composed of hyaluronic acid and glycoproteins (Felson 2015). 
 
Figure 3: Synovial Membrane of the Hip Joint. Synovial membrane is shown in green 
(modified from Drake, Vogl, and Mitchell 2012). 
 
Femoral head
Acetabulum
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Osteoarthritis Pathology 
 
Cartilage Degeneration 
Early in the disease progression, articular cartilage of the affected joint becomes 
irregular due to uneven cartilage loss (Felson 2015). The role of cartilage as a shock-
absorber is compromised as it wears down, which propagates further damage (Roach, H 
and Tilley, S 2007).  Chondrocytes in the damaged area undergo mitosis, producing 
clusters of cells similar to those seen in the proliferative zone of endochondral 
ossification. This causes a local decrease in proteoglycan concentration, and subsequent 
decrease in cartilage elasticity and strength (Felson 2015). 
In contrast to healthy cartilage, OA cartilage is prone to vascular invasion from 
subchondral bone. Loss of proteoglycans and expression of vascular endothelial growth 
factor (VEGF) by chondrocytes are two mechanisms that have been observed to 
contribute to vascularization of OA cartilage (Sunita Suri and Walsh 2012). Clinically, 
cartilage loss is assessed radiographically and it presents as joint space narrowing on 
radiographs (Felson 2015). 
 
Osteophytes 
Osteophytes are bony outgrowths that form in the non-weight bearing regions of 
the femoral head after the cartilage has degenerated (Roach, H and Tilley, S 2007). They 
form from projections of cartilage that ossify instead of re-covering the area of cartilage 
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damage (Felson 2015). Osteophytes can be small or large, and can restrict joint 
movement and cause pain (Roach, H and Tilley, S 2007). 
 
Figure 4: Articular Surface of Osteoarthritic Femoral Head. Cartilage degeneration 
and osteophytes are visible in this image of Sample 157. 
 
Subchondral Cysts 
As articular cartilage degenerates, cytokines signal activation of osteoclasts and 
osteoblasts to remodel the subchondral bone (Felson 2015). Cartilage in the weight-
bearing region of the femoral head articular surface is the first to degenerate (Roach, H 
and Tilley, S 2007). Within these regions bone is lost with the formation of structures 
termed subchondral cysts. These areas of bone loss occur more frequently in subchondral 
trabecular bone since these areas remodel significantly more than deep trabecular bone 
(Li et al. 2015). Because of the differences between male and female bone density, it was 
hypothesized that males and females would have different bone remodeling parameters, 
but Li et al. found that there was no significant difference (Li et al. 2015). This finding 
could be due to analysis of osteoarthritic femoral heads only- no age-matched healthy 
femoral heads were analyzed (Li et al. 2015). 
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Two competing theories exist for the formation of subchondral bone cysts in OA: 
the “fluid breach theory” and the “bony contusion theory”. The fluid breach theory posits 
that cyst formation is initiated by synovial fluid leaking through cracks in the articular 
cartilage into the subchondral bone (Landells 1953). The bony contusion theory states 
that bone that is overloaded or incorrectly loaded dies and is liquefied and subsequently 
removed by osteoclasts, creating a cyst. This theory is supported by a 2015 study by 
Chen et al., where subchondral cysts from subjects with knee OA were analyzed using 
micro computed tomography (µCT) and histology. The finding that trabeculae 
surrounding cysts had a stiffer microarchitecture and higher BMD, combined with 
confirmation of increased osteoblast and osteoclast activity, suggested to the authors that 
the bony contusion theory is more accurate than the fluid breach theory (Chen et al. 
2015). 
 
Subchondral Bone Sclerosis 
 Bone sclerosis is a hallmark of OA, and is simply an increase in bone density 
caused by increased bone turnover and prolonged period of tissue mineralization (Hügle 
and Geurts 2016). Klose-Jensen et al. found that in human OA, increased bone turnover 
occurs before subchondral bone sclerosis. They also found that bone volume was 
maximum in the area of most severe cartilage degradation, but bone turnover increases in 
other regions underlying lesser cartilage degradation. These findings indicate that OA is 
caused by excessive bone formation in all areas of the femoral head, including outside the 
weight bearing region (Klose-Jensen et al. 2015). 
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Detection of OA 
 
Clinical Findings & X-Ray 
 The American College of Rheumatology identifies important clinical criteria for 
correctly classifying DJD as OA. They are: reduced internal rotation or internal rotation 
with pain, hip stiffness in the morning, and advanced age. OA patients develop symptoms 
gradually, often beginning with stiffness and progressing to pain during motion that is 
relieved by rest (Hellmann and Imboden Jr. 2017). Mild, but not severe, inflammation of 
the affected joint is possible (Hellmann and Imboden Jr. 2017). The observations of 
osteophytes and joint cavity narrowing in radiographs, along with clinical findings, 
confirm hip OA (Altman et al. 1991).  
 
MRI Lesions 
 Magnetic Resonance Imaging (MRI) is useful as a diagnostic tool because, unlike 
x-ray, it can differentiate between bone, cartilage, and soft tissue (Roemer et al. 2009). 
OA associated Bone Marrow Lesions (BMLs) are ill-defined regions directly underneath 
damaged articular cartilage. They may be present anywhere in the subchondral bone of 
the joint affected by OA. BML volume has been found to be directly proportional to the 
extent of cartilage loss and radiographic joint space narrowing (Roemer et al. 2009). MRI 
is useful in discriminating OA from other diseases that cannot be detected using clinical 
signs and x-ray, like transient osteoporosis (Roach, H and Tilley, S 2007). The exact 
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histological nature of MRI lesions to structural loss and tissue composition has not been 
well defined. 
 
Relationship of Nerves and Blood Vessels in the Development of OA 
 Cluster of Differentiation 31 (CD31) is a marker used for detecting the 
endothelium of blood vessels. In humans, marrow sinusoids, marrow arterioles, and 
capillaries are CD31-positive (Lafage-Proust et al. 2015). In 2016, Shabestari et al. used 
CD31 as a tool for histologically identifying the extent of vascularity in MRI-identified 
BMLs in subjects with hip OA. They found that BMLs had significantly greater 
vascularity, and that angiogenesis occurred in these regions (Shabestari et al. 2016). 
Vascular invasion of subchondral bone in a rabbit model of knee OA was studied by 
Saito et al. in 2012. The conclusion was that increased angiogenesis of the osteochondral 
junction preceeded increased vascular invasion, and that both processes are features of 
early OA (Saito et al. 2012). These findings suggest that samples taken from subjects 
with late-stage hip OA should have an increased number of blood vessels, and that they 
will be CD31-positive. 
Protein Gene Product 9.5 (PGP 9.5) is a peripheral nerve marker that has been 
used in several recent studies assessing potential causes of pain in musculoskeletal 
disease. Cher et al. used PGP 9.5 to visualize nerves in the shoulder capsule of subjects 
with frozen shoulder- a common musculoskeletal disability. The hypothesis that nerve 
fiber density would be increased in affected samples was upheld (Cher et al. 2017). 
Netzer et al.’s 2016 study of lumbar facet joint OA found PGP 9.5 positive nerve fibers in 
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bone samples from affected subjects, though they were not exclusively present in areas of 
pathological bone structure. This study found that PGP 9.5 positive nerve fibers were 
closely associated with blood vessels (Netzer et al. 2016). Suri et al. successfully used 
PGP 9.5 to visualize nerves in articular cartilage near the osteochondral junction and the 
bone marrow cavity of osteophytes from tibial plateaus of subjects with tibiofemoral OA. 
The nerve fibers were near blood vessels in these two locations. Free nerve fibers were 
found in subchondral bone marrow. From these observations, it was concluded that 
nerves grow into articular cartilage and osteophytes from subchondral bone (S. Suri et al. 
2007). 
 
Objectives  
Osteoarthritis is the most prevalent degenerative joint disease, and it is projected 
to affect an increasing number of people due to the aging population. Treatment options 
are currently limited, and though total hip arthroplasty is effective, it is only performed 
once patients have advanced hip OA. Understanding the underlying biological 
mechanisms that lead to the progression of OA and development of chronic pain is a 
crucial step in identifying more effective treatments that treat the specific underlying 
causes of OA and the development of non-treatable pain.  
The aims of this study were: (1) to develop a reproducible histological technique 
to identify blood vessels and nerve in bone sections; and (2) to apply this protocol to 
identify blood vessel and nerve characteristics within osteoarthritic femoral heads. 
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In future, a larger sample set will be used to correlate the nature of blood vessel 
density and nerves that are found in bone marrow lesions identified on MRI scans 
obtained before surgery and are associated with bone cysts. This is an important step 
towards identifying more effective treatments for OA that address the specific underlying 
causes and the development of non-treatable pain. 
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METHODS 
 
Femoral Head Collection 
Femoral heads were collected from subjects (n=3; age range: 40-58; sex: 2 female 
and 1 male; side: 2 right and 1 left) undergoing total hip arthroplasty as a treatment for 
late stage OA at Boston Medical Center in 2017. Subjects were consented according to 
HIPAA guidelines prior to the surgery and were offered a copy of the consent form. 
Subjects were male and female, and were between the ages of 40 and 58 years old. 
Samples were collected from either side of the body. Samples collected prior to 2017 
(n=5; age range: 45-76; sex: 3 female and 2 male; side: 1 right and 4 left) were also used 
in this study, and were collected and processed in the same way (Table 1).  
 
Table 1. Subjects Enrolled in the Study 
Subject # Sex Age Side 
111 M 70 Left 
119 F 72 Left 
130 F 55 Left 
131 F 76 Left 
133 M 45 Right 
152 F 40 Right 
157 M 58 Right 
180 F 50 Left 
 
Samples were placed into phosphate-buffered saline (PBS) with 1% 
penicillin/streptomycin immediately upon collection from the operating room. Within 30 
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minutes of each surgery, the neck was separated from the head using a reciprocating saw 
(Dremel, WI), and the head was placed into 4% paraformaldehyde at 4ºC. To maintain 
tissue integrity for imaging and histology, samples were fixed in paraformaldehyde 
(PFA). Different fixation times were tested in three samples to assess the effect of 
fixation time on binding of the primary antibody to the target. Each sample was 
processed differently, according to table 2. Samples collected prior to 2017 were all in 
PFA for two weeks. After fixation in PFA, samples were placed into 1x PBS with 1% 
penicillin/streptomycin to await µCT scanning.  
 
Table 2. Sample Processing 
Sample # Time in PFA at 4ºC 
152 2 weeks 
157 1 week 
180 0 weeks 
 
Femoral Head Sectioning 
Samples were scanned using a Zeiss Xradia µCT (Zeiss, Germany) to identify 
cyst regions then sectioned with an IsoMet 4000 brand low-speed abrasive rotating blade 
(IsoMet, VA) (Figure 5). Each section was numbered, photographed, and stored in 1x 
PBS with 1% penicillin/streptomycin. 
The samples were cut into smaller pieces to eventually fit onto a 75mm by 25mm 
microscope slide with the Dremel reciprocating saw (Figure 6). The samples were then 
placed into PFA for a second time to complete the fixation process. Sample 152 and 
Sample 157 were in PFA for one week, and Sample 180 was in PFA for two days.  
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Figure 5: Method for cutting large sections. Left: µCT image of Sample 152 in 
anatomical position; Right: Sample 152 prior to being cut with the IsoMet 4000, with 
black lines indicating where cuts will be made 
 
Figure 6: Method for cutting small sections. Left: µCT image of Sample 152 showing 
regions of varying bone density and orientation of trabeculae; Right: Picture of Sample 
152A prior to being cut with the Dremel, with black lines indicating where cuts will be 
made 
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Decalcification 
Following PFA, the samples were washed with 1x PBS for approximately 1 hour 
to remove residual PFA on the tissue surface. They were then decalcified in 14% 
Ethylenediamenetetraacetic acid (EDTA) for three weeks. Each sample was placed in a 
nylon mesh biopsy bag containing an index card with the sample number written on it in 
pencil, then all samples were put into a large container in the cold room at 4ºC on a 
rocking shaker. EDTA was changed every 3-4 days.  
After three weeks, samples were tested with a 30-gauge needle to check for 
consistency. Samples that were soft, with a tofu-like consistency, were x-rayed to 
confirm that they were completely decalcified. Samples that were not found to have 
opaque regions of calcified bone were then fixed in 4% PFA for a third time overnight, 
washed in PBS for 30 minutes, and placed in 70% Ethanol. 
 
Histology 
Samples were embedded in paraffin, and 15x 5µm thick slices were mounted on 
slides. Each slide was inspected for artefact, and the slides with the fewest artefacts were 
prioritized for staining. Two serial slides were selected and stained with Hematoxylin & 
Eosin (H&E) to visualize overall tissue morphology, and Safarin-O/Fast Green to 
visualize cartilage. A third slide was stained with PGP 9.5 (Sigma-Aldrich Product 
#SAB4503057) to visualize peripheral nerve, and a fourth slide was stained with an 
antibody to CD31 (Invitrogen Product #PA5-29166). 
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Figure 7: Staining Methods Overview. Top center: Photo of Sample 152A1 before 
decalcification; Middle left: Histological section of Sample 152A1 stained with H&E; 
Middle right: Histological section of Sample 152A1 stained with Safarin-O/Fast Green; 
Bottom left: Histological section of Sample 152A1 stained with an antibody to PGP9.5; 
Bottom right: Histological section of Sample 152A1 stained with an antibody to CD31 
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The different staining techniques allowed for identification of several important 
features. Samples were scanned for the presence of sclerotic bone, osteophytes, and 
subchondral bone cysts. The subchondral bone cysts were further classified using 
visualization with H&E and Saf-O. 
 
 
Immunohistochemistry 
Slides to be stained with PGP 9.5 were first deparaffinized in xylene and ethanol. 
The samples were then either heat-retrieved, or not. Heat retrieval was performed by 
placing slides in a tray containing antigen unmasking solution (Vector, PA). The samples 
were microwaved for five minutes on power four, then five minutes on power three, and 
finally for five minutes on power three again. Samples were allowed to cool slightly 
before continuing to the blocking steps. 
Both heat-retrieved and non-heat-retrieved samples were then treated with a 
hydrogen peroxide block (abcam) for ten minutes, washed with 1x PBS, and treated with 
a protein block (abcam) for 10 minutes. After washing again with 1x PBS, treated with 
the primary antibody. The primary antibody used was anti-PGP 9.5 (Sigma Aldrich) 
diluted 1:50, 1:100, or 1:500 with 1x PBS and 1% BSA. Samples were incubated 
overnight at 4ºC. The following day, samples were washed with 1x PBS, then treated 
with HRP-conjugate (abcam) for 15 minutes. Samples were washed again, then in some 
samples the target was amplified.  
 22 
For amplification, samples were treated with biotin tyramide (Perkin Elmer) for 
10 minutes at room temperature. Samples were then washed with 1xPBS, and treated 
with streptavidin-HRP (Perkin Elmer) for 30 minutes at room temperature.  
After washing with 1xPBS, both amplified and non-amplified samples were 
treated with DAB chromogen/DAB substrate (abcam) for 8 minutes at room temperature. 
The samples were then either counterstained with Hematoxylin by dipping once, or not. 
A coverslip was applied using EcoMount mounting medium (BioCare Medical).   
This procedure was optimized using Sample 133, which was collected prior to 
2017. 
 
Table 3. PGP 9.5 Staining Trials for Sample 133 
Slide ID Concentration Hematoxylin Heat Retrieval Amplification 
A 1:50 + - - 
B 1:100 + - - 
C 1:500 + - - 
D 1:50 + + - 
E 1:100 + + - 
F 1:500 + + - 
G 1:100 - - + 
H 1:100 - - - 
 
The staining protocol for CD31 was the same as the staining protocol for PGP 9.5, 
but fewer trials were done to find the optimal staining method. Sample 119, another 
sample collected prior to 2017, was used for this experiment. 
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Table 4. CD31 Staining Trials for Sample 119 
Slide ID Concentration Hematoxylin Heat Retrieval Amplification 
A 1:100 - - + 
B 1:100 - + + 
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RESULTS 
 
Subject Demographics 
 
 Femoral heads were collected from subjects (n=3; age range: 40-58; sex: 2 female 
and 1 male; side: 2 right and 1 left) undergoing total hip arthroplasty as a treatment for 
late stage OA at Boston Medical Center in 2017 (Table 5). Samples collected prior to 
2017 (n=5; age range: 45-76; sex: 3 female and 2 male; side: 1 right and 4 left) were also 
used in this study (Table 6). 
 
Sclerotic Bone 
 Identifying sclerotic bone was important because sclerotic bone is found around 
subchondral cysts in OA (Glyn-Jones et al. 2015). Trabecular bone with increased density 
was identified as sclerotic bone.  Figure 8 shows several samples that were positive for 
subchondral bone sclerosis. All eight samples had sclerotic bone (Table 7). 
 
Subchondral Bone Cysts 
 
 Each sample was surveyed for the presence of subchondral bone cysts in the 
region that was processed for histology. Cysts are regions where the normal trabecular 
bone and marrow are displaced by another tissue type. Cysts were identified as fibrous, 
fatty, or as having a cartilage intrusion. These respective categories identify the tissue 
that pathologically replaces subchondral bone during the disease progression of OA. 
Sample 180 did not have a cyst. 
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Table 5. Subject Demographics. 
 
Subject # 152 157 180 
Sex F M F 
Age 40 58 50 
Side Right Right Left 
Race N/A White White 
BMI [kg/m2] 32.6 29.71 27.4 
Height [cm] 163 176 163 
Weight [kg] 86.2 92 72.4 
Diabetes No No No 
Renal Disease No No No 
History of steroid use No No No 
Alcohol abuse No Yes Former 
Smoking status No 0.25PPD Former 
Vitamin D level [ng/mL] N/A 22.2 34.1 
Hemoglobin A1C 5.1 5.8 5.1 
Cardiovascular disease No No No 
Sickle cell No No No 
BP (systolic/diastolic) 130/78 112/72 123/72 
Heart rate 101 89 84 
Multiple limb OA No Yes No 
HTN No Yes No 
Hyperlipidemia No No Yes 
Osteoporosis No No No 
Osteonecrosis No Yes No 
Low bone mass No No No 
Diagnosis if ≤40 y/o 
Primary diagnosis 
OA, Secondary 
diagnosis Smith 
Magenis 
syndrome   
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Table 6. Subject Demographics- Samples collected prior to 2017 
 
Subject # 111 119 130 131 133 
Sex M F F F M 
Age 70 72 55 76 45 
Side Left Left Left Left Right 
Race 
White 
African 
American 
African 
American 
White White 
BMI [kg/m2] 39.1 28 28.6 33.6 29.5 
Weight [kg] 115 N/A 87.9 83.3 100.9 
Diabetes No DM No No No 
Renal Disease 
No 
Renal 
Insufficiency 
No No No 
History of 
steroid use 
No No No No No 
Alcohol Abuse No No No No No 
Smoking 
Status 
Former Former 1/2 PPD N/A 1/2 PPD 
Vitamin D 
Level 
N/A 24.6 N/A N/A N/A 
 
 
Table 7: Histologically Identified Sclerotic Bone 
Sample 
111 
Sample 
119 
Sample 
130 
Sample 
131 
Sample 
133 
Sample 
152 
Sample 
157 
Sample 
180 
+ + + + + + + + 
 
Osteophytes 
 The articular surface of each sample was analyzed for cartilage loss. Areas where 
the cartilage was completely eroded, and the sclerotic bone was continuous with the 
surface, were identified as osteophytes. Six out of eight samples had an osteophyte (Table 
9).  
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Sample 180      Sample 111 
 
Sample 152      Sample 157 
                                     
Figure 8: Sclerotic Bone. Four samples with arrows pointing to regions of sclerotic 
bone.     
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Table 8: Histologically Identified Subchondral Bone Cysts 
 
Sample 
111 
Sample 
119 
Sample 
130 
Sample 
131 
Sample 
133 
Sample 
152 
Sample 
157 
Sample 
180 
Fibrous 
Cyst 
- + + + - + + - 
Fatty 
Cyst + - - - + - - - 
Cartilage 
Intrusion 
- + - - - - - - 
 
 
 
 
Figure 9: Fibrous Cyst. Arrow pointing to fibrous cyst region of Sample 157 stained 
with H&E 
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Figure 10: Cartilage Intrusion. Left: Arrow pointing to region of interest containing 
cartilage intrusion; Right: Region of interest magnified 4x 
 
 
Table 9: Histologically Identified Osteophytes 
Sample 
111 
Sample 
119 
Sample 
130 
Sample 
131 
Sample 
133 
Sample 
152 
Sample 
157 
Sample 
180 
- + + + + + + - 
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Figure 11: Osteophyte. Left: The blue sclerotic bone is continuous with the articular 
surface of this sample. Healthy cartilage would appear red when stained with Safarin-
O/Fast Green. Arrow points to the region of interest; Right: Region of interest magnified 
4x 
 
 
Nerve Characteristics 
 Nerves were visualized with an antibody to PGP 9.5. Sample 133 was used to test 
different concentrations of the primary antibody, the effect of counterstaining with 
Hematoxylin, and the effect of using a heat retrieval method (Figures 12 and 13). 
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Figure 12: Sample 133 Region of Interest. Top Left: H&E with arrow pointing to 
region containing vessels and nerves; Top Right: H&E region of interest magnified 4x 
with arrow pointing to nerve; Bottom Left: PGP 9.5 without Hematoxylin, heat retrieval, 
or amplification, with arrow pointing to region containing vessels and nerves; Bottom 
Right: Region of interest magnified 4x stained with PGP 9.5 without Hematoxylin, heat 
retrieval, or amplification, with arrow pointing to nerve 
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Figure 13: Sample 133 Nerve Magnified 20x. A: PGP 9.5 1:50 dilution counterstained 
with Hematoxylin; B: PGP 9.5 1:100 dilution counterstained with Hematoxylin; C: PGP 
9.5 1:500 dilution counterstained with Hematoxylin; D: PGP 9.5 1:50 dilution 
counterstained with Hematoxylin and heat-retrieved; E: PGP 9.5 1:100 dilution 
counterstained with Hematoxylin and heat-retrieved; F: PGP 9.5 1:500 dilution 
counterstained with Hematoxylin and heat-retrieved  
 
  
After performing this test, it was concluded that the optimal dilution was 1:100. 
Heat retrieval and Hematoxylin were removed from the protocol to attempt to reduce 
artefactual folding of the tissue (figure 14). The 1:100 dilution was then used to stain 
Sample 133, followed by amplification (figure 15). 
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Sample 133-H  Sample 133-B  Sample 133-E 
 
Figure 14: Artefactual folds in PGP 9.5-stained tissue. Left: Sample 133-H: PGP 9.5 
1:100 dilution; Middle: Sample 133-B: PGP 9.5 1:100 dilution counterstained with 
Hematoxylin; Right: Sample 133-E: PGP 9.5 1:100 dilution counterstained with 
Hematoxylin and heat-retrieved 
 
 
 
Figure 15: The effect of amplification on staining with PGP 9.5. Left: Sample 133-H: 
PGP 9.5 1:100 dilution magnified 20x; Right: Sample 133-G: PGP 9.5 1:100 dilution 
with amplification magnified 20x 
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After completing the experiments to evaluate the optimal staining conditions for 
PGP 9.5, all samples were stained and evaluated for PGP 9.5-positive nerves (Table 10). 
Special attention was paid to the cyst regions of samples that had fibrous subchondral 
bone cysts because these are the most likely type to undergo neurovascular invasion 
(Table 11). 
 
Table 10: PGP 9.5-Positive Nerves 
Sample 
111 
Sample 
119 
Sample 
130 
Sample 
131 
Sample 
133 
Sample 
152 
Sample 
157 
Sample 
180 
+ - + + + - + - 
 
 
Table 11: PGP 9.5-Positive Nerves Within Fibrous Subchondral Bone Cysts 
Sample 119 Sample 130 Sample 131 Sample 152 Sample 157 
- + + - + 
 
 In each sample containing a PGP 9.5-positive nerve, the nerve was close to a 
muscular artery. In Sample 111, the nerve was located close to the border between the 
femoral head and neck (Figure 16). Sample 130 had a nerve in the fibrous cyst region 
(Figure 17). The nerve was surrounded by several muscular arteries and dense irregular 
connective tissue. Sample 131 had nerves in both cyst and non-cyst regions, but a nerve 
from the non-cyst region was chosen for Figure 18 because the cyst region of this sample 
was not well preserved. Sample 157 had a nerve in the fibrous cyst region (Figure 19). 
This sample was in PFA for only one week prior to decalcification, with the goal of 
comparing the staining properties of the nerves in this sample to those of samples fixed 
for two weeks. Qualitatively, the nerve in Sample 157 does not appear to have had better 
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binding to the PGP 9.5 antibody; it is not darker than its counterparts in the other 
samples. Sample 157 also did not appear to have a greater frequency of stained nerves 
than the other samples. 
 
 
 
 
Figure 16: PGP 9.5-Positive Nerve in a Non-Cyst Region of Sample 111. Left: 
Overview image of Sample 111 with arrow pointing to region of interest containing 
nerve; Right: Region of interest with arrow pointing to PGP 9.5-positive nerve magnified 
10x 
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Figure 17: PGP 9.5-Positive Nerve in Fibrous Cyst Region of Sample 130. Left: 
Overview image of Sample 130 with arrow pointing to region of interest containing 
nerve; Right: Region of interest magnified 10x 
 
 
 
 
Figure 18: PGP 9.5-Positive Nerve in a Non-Cyst Region of Sample 131. Left: 
Overview image of Sample 131 with arrow pointing to region of interest containing 
nerve; Right: Region of interest magnified 10x with arrow pointing to PGP 9.5-positive 
nerve 
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Figure 19: PGP 9.5-Positive Nerve in Fibrous Cyst Region of Sample 157. Left: 
Overview image of Sample 157 with arrow pointing to region of interest containing 
nerve; Right: Region of interest magnified 10x with arrow pointing to leftmost portion of 
PGP 9.5-positive nerve. The nerve runs longitudinally relative to the muscular artery near 
it 
 
 
Blood Vessel Characteristics 
 Blood vessels were visualized with an antibody to CD31. Sample 119 was 
identified to have blood vessels present in H&E, and was therefore used to test different 
staining conditions (Figure 20).  
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Sample 119-A 
 
Sample 119-B 
 
Figure 20: Blood vessels stained with CD31 with and without heat retrieval. Top left: 
overview of Sample 119 stained without heat retrieval. Top right: CD31-marked blood 
vessels magnified 10x. Bottom left: overview of Sample 119 stained with heat retrieval. 
Bottom right: CD31-marked blood vessels magnified 10x 
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 As with PGP 9.5, samples that were heat-retrieved and stained with CD31 had 
more artefactual folds than samples that were not heat-retrieved. The folds in some cases 
completely obscured the blood vessels. It was concluded that heat-retrieval was not 
necessary for visualizing vessels. 
Samples stored in PFA for varying amounts of time were used to evaluate the 
effect of time spent in PFA on clarity of antibody stain. Sample 152 was fixed in PFA for 
two weeks prior to decalcification, and was found to have a CD31-positive arteriole 
(Figure 21). The arteriole found in Sample 152, compared to blood vessels in Samples 
157 and 180, which were fixed for one week and zero weeks respectively, qualitatively 
appears to have the same ability to bind the CD31 antibody. Sample 180 had fewer blood 
vessels than Samples 152 and 157, and did not have any CD31-positive muscular arteries. 
An arteriole from Sample 180 is shown in Figure 22. Figure 23 shows several arterioles 
and a muscular artery in Sample 157. 
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Figure 21: CD31-Positive Blood Vessel in Cyst Region of Sample 152. Left: Overall 
image of Sample 152 stained with CD31 with arrow pointing to region of interest; Right: 
CD31-positive arteriole within the region of interest magnified 4x 
 
 
Figure 22: CD31-Positive Blood Vessel in a Non-Cyst Region of Sample 180. Left: 
Overall image of Sample 180 stained with CD31 with arrow pointing to region of 
interest; Right: Blood vessel positive for CD31 magnified 4x 
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Figure 23: CD31-Positive Blood Vessels in Fibrous Cyst Region of Sample 157. Left: 
Overall image of Sample 157 stained with CD31 with arrow pointing to region of interest 
within the fibrous subchondral cyst; Right: Within the region of interest, several CD31-
positive blood vessels can be seen at 4x magnification 
 
 
 After completing the experiments to evaluate the optimal staining conditions for 
CD31, all samples were stained and evaluated for CD31-positive vessels (Table 12). 
Special attention was paid to the cyst regions of samples that had fibrous subchondral 
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bone cysts (Table 13). All samples were found to have CD31-positive vessels. A cluster 
of vessels typical of those found in fibrous cyst regions is shown in figure 24. 
 
Table 12: CD31-Positive Blood Vessels 
Sample 
111 
Sample 
119 
Sample 
130 
Sample 
131 
Sample 
133 
Sample 
152 
Sample 
157 
Sample 
180 
+ + + + + + + + 
 
 
 
 
Table 13: CD31-Positive Blood Vessels Within Fibrous Subchondral Bone Cysts 
Sample 119 Sample 130 Sample 131 Sample 152 Sample 157 
+ + + + + 
 
 
Figure 24: CD31-Positive Blood Vessels in Cyst Region of Sample 119. Left: Overall 
image of Sample 119 stained with CD31 with arrow pointing to region of interest 
within fibrous subchondral bone cyst; Right: Blood vessels positive for CD31 
magnified 10x 
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DISCUSSION 
 
OA affects the whole hip joint, and causes pathological subchondral bone 
remodeling resulting in subchondral bone cysts, osteophytes, and cartilage loss. With this 
remodeling, an increased number of blood vessels was expected and has been observed in 
human samples (Shabestari et al. 2016). Nerves are known to be associated with vessels, 
therefore an increase in the number of peripheral nerves in OA bone was expected, 
although it had not been previously demonstrated in subchondral bone of osteoarthritic 
femoral heads. In this study, a reproducible histological technique to identify blood 
vessels and nerve in bone sections was created and applied to osteoarthritic femoral 
heads. Analysis of sclerotic bone, subchondral bone cysts, and osteophytes was done to 
establish the environment of the regions in which blood vessels and nerves were found. 
 
Histological Technique 
 The immunochemistry techniques designated as optimal were selected to 
maximize signal intensity from target tissues while minimizing tissue folding and 
background signal. For both anti-CD31 and anti-PGP 9.5, a 1:100 dilution and 
amplification were optimal. In future, heat-retrieval may work well for increasing signal 
intensity in samples that do not stain well with amplification and without heat-retrieval. 
Counterstaining with Hematoxylin, which was also found to increase tissue folding, may 
be used if basophilic structures need to be identified. In this study, use of samples stained 
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with Safarin-O/Fast Green allowed visualization of cartilage, so it was not as necessary to 
counterstain immunohistochemistry slides with Hematoxylin. 
 The effect of fixation time on the staining properties of nerves in osteoarthritic 
marrow regions of the femoral head was unable to be determined due to the lack of 
visible nerves in Sample 152 and Sample 180. Sample 157, which was only fixed for one 
week before decalcification, had PGP 9.5 positive nerves, but the number and image 
quality was not qualitatively different from the samples with a longer fixation period.  
 Both CD31 and PGP 9.5 stained tissues that were clearly not blood vessel 
endothelium and nerve, respectively. Red blood cells were frequently observed to be 
stained. When identifying nerves, the possibility of artefactual staining of non-target 
tissue was taken into account to avoid falsely identifying blood-filled veins and venules 
as nerves. Location was a useful indicator. For example, sometimes a structure would 
appear to be a nerve, but if it was followed through the tissue it was actually continuous 
with a vessel. Osteoblasts were also observed to be positive for PGP 9.5, but the cuboidal 
morphology of these cells is dissimilar to the structure of peripheral nerves, so it was not 
difficult to correctly identify them as osteoblasts. In many cases, reference to the 
corresponding slide stained with H&E was also useful for determining the identity of 
structures stained with PGP 9.5. 
 
Blood Vessel and Nerve Characteristics Within Osteoarthritic Femoral Heads 
All eight samples were found to have sclerotic bone. The sclerotic bone was used 
to identify subchondral bone cysts. Since all samples were from subjects with late stage 
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OA, this was an anticipated result. Six out of eight samples were found to have 
osteophytes.  
 Seven out of eight samples were found to have subchrondral bone cysts upon 
histological analysis. Sample 180 did not have an identifiable cyst region on µCT, and 
correspondingly did not have a histologically identified subchondral bone cyst.  
All eight samples had CD31-positive blood vessels. All five samples with fibrous 
subchondral bone cysts had CD31-positive blood vessels in the cyst region. In future, the 
anti-CD31 stain can be used to quantify the number of blood vessels in each sample, and 
compare the blood vessel characteristics of different types of cysts. 
PGP 9.5-positive nerves were found in five out of eight samples. Three out of five 
samples containing fibrous subchondral bone cysts had PGP 9.5-positive nerves in the 
cyst region. All nerves identified were close to a muscular artery. In future, the anti-PGP 
9.5 stain can be used to compare the location and quantity of nerves in different types of 
cysts. 
The articular cartilage of Sample 130 superficial to the nerve was not well 
preserved, but it was concluded that fibrous tissue near where the articular cartilage 
represented a cyst region. This fibrous tissue contained nerves and vessels, but due to the 
damage in the surrounding region, images of these structures were not included. 
In future, a larger sample set will be used to correlate the nature of blood vessel 
density and nerves that are found in bone marrow lesions identified on MRI scans 
obtained before surgery and are associated with bone cysts. Quantification of nerve and 
blood vessel characteristics has not been performed prior to this study. Comparison of 
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these structures within different types of subchondral bone cysts will show which tissue 
composition is most likely to have pathological blood vessel and nerve growth. For 
example, in this study most of the samples had fibrous cysts, but with a larger sample size 
there will be more cartilage intrusions to compare. With this larger sample size, it will be 
possible to tell whether fibrous cysts or cartilage intrusions have more blood vessels and 
nerves. Comparison will also be made between cysts of different size and location 
relative to the articular surface. This level of specific analysis of subchondral bone cysts 
has not yet been described in the literature. If nerve is found in subchondral bone cysts, 
the cause of pain associated with hip OA will be elucidated. This is an important step 
towards identifying more effective treatments for OA that address the specific underlying 
causes and the development of non-treatable pain. 
 
Limitations 
This study had several limitations. Ideally, when sectioning samples using the 
Isomet 4000, coronal slices should be obtained to keep the plane of section constant 
between samples and constant with previous studies done. Coronal slices could not be 
obtained because the clamp holding the sample in place on the Isomet 4000 was not large 
enough. Additionally, to aid in dissecting out cysts, a cyst overlay should be used to 
visualize cyst position relative to the cutting plane.  
The small sample size of this study was a limitation with regard to identifying 
blood vessel and nerve characteristics within osteoarthritic femoral heads. This limitation 
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will be overcome in the next study, where 50 samples will be processed according to the 
procedure developed here. 
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CONCLUSION 
 
 All eight samples had CD31-positive blood vessels. All five samples with fibrous 
subchondral bone cysts had CD31-positive blood vessels in the cyst region. If BMLs 
accurately represent histological cyst regions, then his result agrees with the finding of 
Shabestari et al. in 2016 that MRI-identified BMLs had CD31-positive vessels 
(Shabestari et al. 2016). The antibody to CD31 worked best under the conditions of no 
heat-retrieval or Hematoxylin-counterstain. Fixation time did not have an effect on 
staining with CD31. 
 
 PGP 9.5-positive nerves were found in five out of eight samples. Three out of five 
samples containing fibrous subchondral bone cysts had PGP 9.5-positive nerves in the 
cyst region. All nerves identified were close to a muscular artery. This result is consistent 
with the finding of Netzer et al. in 2016 that PGP 9.5-positive nerves in bone from 
subjects with lumbar spinal stenosis were associated with arteries (Netzer et al. 2016). 
The antibody to PGP 9.5 worked best under the conditions of no heat-retrieval or 
Hematoxylin-counterstain. 
 
 Developing reproducible procedures for staining with anti-CD31 and anti-PGP 
9.5 is an important step in protocol development. The next study will use these 
procedures to identify blood vessels and nerves so that these structures can be accurately 
compared with MRI-identified BMLs.   
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 The association between subchondral bone cysts and pain has been studied in hip 
OA, but the exact histological nature of MRI lesions to structural loss and tissue 
composition has not been well defined. Subjects with OA-associated bone cysts were 
found to have more pain than subjects without bone cysts (Kumar et al. 2013). If 
subchondral bone cysts were identified to be correlated with MRI-identified BMLs, then 
it could be concluded that BMLs are associated with structures known to cause pain. This 
would be a useful tool in the clinic for identifying when and how to treat osteoarthritic 
pain. 
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